Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP625450.RAWP7WyVP3Ni8ACrn2TAabMQh8m8nfMgZmWF1bqZDRWBg130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625450.RAWP7WyVP3Ni8ACrn2TAabMQh8m8nfMgZmWF1bqZDRWBg130_provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1108203.RATb8o9sgWDiQt0emO1J3-V2cMpkjNVJliZr-3jG8LqEI130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108203.RATb8o9sgWDiQt0emO1J3-V2cMpkjNVJliZr-3jG8LqEI130_provenance.
• NP1108211.RAWuWeAbS05Lf2PIAfdNTeVCDTd3PHhNaOAhnbiemb1Ds130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108211.RAWuWeAbS05Lf2PIAfdNTeVCDTd3PHhNaOAhnbiemb1Ds130_provenance.
• NP1108212.RAYWOzpj5D9Ncyc9Vkp79exnchgl5umtwkPKIxYmUQuWY130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108212.RAYWOzpj5D9Ncyc9Vkp79exnchgl5umtwkPKIxYmUQuWY130_provenance.
• NP622994.RAB5Q23poJtxU18voeS5bVUQ3zKVt8740UDEwNfCbIOdo130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622994.RAB5Q23poJtxU18voeS5bVUQ3zKVt8740UDEwNfCbIOdo130_provenance.
• NP624310.RAnln0fuPRVS8BtwPaOCeSWPa4Qtf9AG240S4o4wp_M2A130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624310.RAnln0fuPRVS8BtwPaOCeSWPa4Qtf9AG240S4o4wp_M2A130_provenance.
• NP624649.RAgeXwvmoApO-clkbpatjYVvHrBZzAA41NcKQKnd4e8To130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624649.RAgeXwvmoApO-clkbpatjYVvHrBZzAA41NcKQKnd4e8To130_provenance.
• NP1108210.RAp4SqD_1wJfZYv80omBoNMeAL3jvqti1UsTOQoGKBM80130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108210.RAp4SqD_1wJfZYv80omBoNMeAL3jvqti1UsTOQoGKBM80130_provenance.
• NP622206.RAz8VC77p8FP17LsJGex6WAhb4HdVghrx5Kz61tqgANEE130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622206.RAz8VC77p8FP17LsJGex6WAhb4HdVghrx5Kz61tqgANEE130_provenance.
• NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623521.RA4HYRkpRRTkgzoIpELseXmwkyfIhfCEB6RU4wlSc-3a4130_provenance.
• NP1108204.RAy36iNAdDH6jYjLD0d2YqF3qtpQdFlJt5RUZa0KVhJoQ130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108204.RAy36iNAdDH6jYjLD0d2YqF3qtpQdFlJt5RUZa0KVhJoQ130_provenance.
• NP1108207.RAyQS8ug7dtTBQqNZLNb2kv1mCmjtaEtJBoo5UBfiE89Q130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108207.RAyQS8ug7dtTBQqNZLNb2kv1mCmjtaEtJBoo5UBfiE89Q130_provenance.
• NP1108209.RAw4X03dcomFVBcEgCfAccEfd0r4OShPdJ9PzM2QBan6A130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108209.RAw4X03dcomFVBcEgCfAccEfd0r4OShPdJ9PzM2QBan6A130_provenance.
• NP1108214.RA8Miz9xVJZmz6JiEcsET9Af3imusC0ZaoMXhwrHLANsY130_assertion description "[The transcriptomic and proteomic signatures of PI3K pathway activation associate with reduced estrogen receptor ? (ER) levels and activity, and with the luminal B subtype of BC that has a relatively poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108214.RA8Miz9xVJZmz6JiEcsET9Af3imusC0ZaoMXhwrHLANsY130_provenance.